BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 21695925)

  • 1. [Treatment of critical limb ischemia and diabetic foot disease by the use of autologous stem cells].
    Dubský M; Jirkovská A; Bém R; Pagácová L; Fejfarová V; Varga M; Skibová J; Langkramer S; Syková E
    Vnitr Lek; 2011 May; 57(5):451-5. PubMed ID: 21695925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wound therapy with autologous bone marrow stem cells in diabetic patients with ischaemia-induced tissue ulcers affecting the lower limbs.
    Kirana S; Stratmann B; Lammers D; Negrean M; Stirban A; Minartz P; Koerperich H; Gastens MH; Götting C; Prohaska W; Kleesiek K; Tschoepe D
    Int J Clin Pract; 2007 Apr; 61(4):690-2. PubMed ID: 17394441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of bone marrow mesenchymal stem cells with bone marrow-derived mononuclear cells for treatment of diabetic critical limb ischemia and foot ulcer: a double-blind, randomized, controlled trial.
    Lu D; Chen B; Liang Z; Deng W; Jiang Y; Li S; Xu J; Wu Q; Zhang Z; Xie B; Chen S
    Diabetes Res Clin Pract; 2011 Apr; 92(1):26-36. PubMed ID: 21216483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Both autologous bone marrow mononuclear cell and peripheral blood progenitor cell therapies similarly improve ischaemia in patients with diabetic foot in comparison with control treatment.
    Dubsky M; Jirkovska A; Bem R; Fejfarova V; Pagacova L; Sixta B; Varga M; Langkramer S; Sykova E; Jude EB
    Diabetes Metab Res Rev; 2013 Jul; 29(5):369-76. PubMed ID: 23390092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transplantation of autologous bone marrow mononuclear cells for patients with lower limb ischemia.
    Gu YQ; Zhang J; Guo LR; Qi LX; Zhang SW; Xu J; Li JX; Luo T; Ji BX; Li XF; Yu HX; Cui SJ; Wang ZG
    Chin Med J (Engl); 2008 Jun; 121(11):963-7. PubMed ID: 18706241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Autologous bone-marrow stem-cell transplantation for induction of arteriogenesis for limb salvage in critical limb ischaemia].
    Amann B; Lüdemann C; Ratei R; Schmidt-Lucke JA
    Zentralbl Chir; 2009 Aug; 134(4):298-304. PubMed ID: 19688676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spinal cord stimulation in diabetic lower limb critical ischaemia: transcutaneous oxygen measurement as predictor for treatment success.
    Petrakis IE; Sciacca V
    Eur J Vasc Endovasc Surg; 2000 Jun; 19(6):587-92. PubMed ID: 10873725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The treatment of advanced chronic lower limb ischaemia with marrow stem cell autotransplantation.
    Nizankowski R; Petriczek T; Skotnicki A; Szczeklik A
    Kardiol Pol; 2005 Oct; 63(4):351-60; discussion 361. PubMed ID: 16273471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcutaneous oxygen tension (TcPO2) in the testing period of spinal cord stimulation (SCS) in critical limb ischemia of the lower extremities.
    Petrakis IE; Sciacca V
    Int Surg; 1999; 84(2):122-8. PubMed ID: 10408282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of a double-blind, placebo-controlled study to assess the safety of intramuscular injection of hepatocyte growth factor plasmid to improve limb perfusion in patients with critical limb ischemia.
    Powell RJ; Simons M; Mendelsohn FO; Daniel G; Henry TD; Koga M; Morishita R; Annex BH
    Circulation; 2008 Jul; 118(1):58-65. PubMed ID: 18559703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complications impaired endothelial progenitor cell function in Type 2 diabetic patients with or without critical leg ischaemia: implication for impaired neovascularization in diabetes.
    Chen MC; Sheu JJ; Wang PW; Chen CY; Kuo MC; Hsieh CJ; Chen JF; Chang HW
    Diabet Med; 2009 Feb; 26(2):134-41. PubMed ID: 19236615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intramuscular transplantation of G-CSF-mobilized CD34(+) cells in patients with critical limb ischemia: a phase I/IIa, multicenter, single-blinded, dose-escalation clinical trial.
    Kawamoto A; Katayama M; Handa N; Kinoshita M; Takano H; Horii M; Sadamoto K; Yokoyama A; Yamanaka T; Onodera R; Kuroda A; Baba R; Kaneko Y; Tsukie T; Kurimoto Y; Okada Y; Kihara Y; Morioka S; Fukushima M; Asahara T
    Stem Cells; 2009 Nov; 27(11):2857-64. PubMed ID: 19711453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prognostic factors for critical limb ischemia after autologous bone marrow implantation].
    Oda M; Kato K; Toba K; Otaki K; Kitajima T; Ikarashi N; Yanagawa T; Higashimura M; Asami F; Isoda M; Ozawa T; Moriyama M; Hirono S; Okura Y; Hanawa H; Kodama M; Aizawa Y
    J Cardiol; 2007 Oct; 50(4):235-42. PubMed ID: 17987839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autologous stem cell therapy in the treatment of limb ischaemia induced chronic tissue ulcers of diabetic foot patients.
    Kirana S; Stratmann B; Prante C; Prohaska W; Koerperich H; Lammers D; Gastens MH; Quast T; Negrean M; Stirban OA; Nandrean SG; Götting C; Minartz P; Kleesiek K; Tschoepe D
    Int J Clin Pract; 2012 Apr; 66(4):384-93. PubMed ID: 22284892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of severe diabetic kidney disease on the clinical outcome of autologous cell therapy in people with diabetes and critical limb ischaemia.
    Dubský M; Jirkovská A; Bem R; Němcová A; Fejfarová V; Hazdrová J; Sutoris K; Chlupáč J; Skibová J; Jude EB
    Diabet Med; 2019 Sep; 36(9):1133-1140. PubMed ID: 31077439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative study on autologous implantation between bone marrow stem cells and peripheral blood stem cells for treatment of lower limb ischemia].
    Gu Y; Zhang J; Qi L
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2007 Jul; 21(7):675-8. PubMed ID: 17694651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Transcutaneous oxygen tension in hyperbaric condition as a predictor of ischaemia in non-healing diabetic foot ulcers].
    Cechurová D; Rusavý Z; Lacigová S; Růzicka J; Novák M; Jankovec Z
    Vnitr Lek; 2002 Oct; 48(10):971-5. PubMed ID: 16737148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intermittent intravenous urokinase for critical limb ischemia in diabetic foot ulceration.
    Weck M; Rietzsch H; Lawall H; Pichlmeier U; Bramlage P; Schellong S
    Thromb Haemost; 2008 Sep; 100(3):475-82. PubMed ID: 18766265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The salvage of ischaemic limb by therapeutical angiogenesis].
    Talapková R; Hudecek J; Sinák I; Kubisz P; Laca L; Hlinka L; Zelenák K
    Vnitr Lek; 2009 Mar; 55(3):179-83. PubMed ID: 19378842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double trouble: infection and ischemia in the diabetic foot.
    Edmonds M
    Int J Low Extrem Wounds; 2009 Jun; 8(2):62-3. PubMed ID: 19443892
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.